SNIS 2026

ALAMEDA, California, July 22, 2026 Penumbra, Inc. has announced positive results from the THUNDER Investigational Device Exemption (IDE) study,...

Maple Grove, Minn., July 22, 2026 Serenity Medical announced new four- to five-year clinical data demonstrating the long-term effectiveness...

SEATTLE & YOKNEAM, Israel, July 21, 2026 Rapid Medical announced U.S. Food and Drug Administration (FDA) clearance of DRIVEWIRE™...